Market Research Logo

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2018

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Glaucoma Surgery Devices Overview
3 Products under Development
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials
4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
5 Glaucoma Surgery Devices Companies and Product Overview
5.1 Assenti, LLC Company Overview
5.1.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Camras Vision Company Overview
5.2.1 Camras Vision Pipeline Products & Ongoing Clinical Trials Overview
5.3 Ellex Medical Lasers Limited Company Overview
5.3.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
5.4 Eye Sonix Company Overview
5.4.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
5.5 Galaxy Ophthalmics Inc Company Overview
5.5.1 Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Geuder AG Company Overview
5.6.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Glaukos Corp Company Overview
5.7.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 iSTAR Medical SA Company Overview
5.8.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.9 Ivantis Inc Company Overview
5.9.1 Ivantis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 iVeena Delivery Systems Inc Company Overview
5.10.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Johns Hopkins University Company Overview
5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Kytogenics Pharmaceuticals Inc Company Overview
5.12.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Massachusetts Eye and Ear Infirmary Company Overview
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
5.14 Medtronic plc Company Overview
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Meir Medical Center Company Overview
5.15.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.16 Merz Anteis SA Company Overview
5.16.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
5.17 MicroOptx, Inc. Company Overview
5.17.1 MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Ocumatrx Company Overview
5.18.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
5.19 OcuTherix Inc Company Overview
5.19.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 OPKO Health Inc Company Overview
5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OptoLight Vision Technology Company Overview
5.21.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
5.22 Queen's University Company Overview
5.22.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview
5.23 Santen Pharmaceutical Co Ltd Company Overview
5.23.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 Sheba Medical Center Company Overview
5.24.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sight Sciences Inc Company Overview
5.25.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 SOLX Inc Company Overview
5.26.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Tel Aviv University Company Overview
5.27.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.28 TonoGuard Ltd. Company Overview
5.28.1 TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Colorado Company Overview
5.29.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Michigan Company Overview
5.30.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Pennsylvania Company Overview
5.31.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Rostock Company Overview
5.32.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview
5.33 Westhouse Medical Services Plc (Inactive) Company Overview
5.33.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Glaucoma Surgery Devices- Recent Developments
6.1 Apr 16, 2018: Ellex iTrack and Ellex Glaucoma Business Third Quarter Sales Update
6.2 Apr 16, 2018: Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial
6.3 Apr 14, 2018: IDE Pivotal Trial Results for Glaukos iStent inject Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery
6.4 Apr 14, 2018: Glaukos Files Patent Infringement Lawsuit Against Ivantis
6.5 Apr 13, 2018: Alcon introduces pre-loaded delivery system for the CyPass Micro-Stent to enhance surgical experience
6.6 Apr 12, 2018: New Data from the HORIZON Trial of the Hydrus Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort
6.7 Apr 11, 2018: Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.9 Mar 20, 2018: Iridex Receives CE Mark for Transilluminated Probe
6.10 Mar 12, 2018: Greater Manchester trust treats first patients outside of USA with ground-breaking device the size of an eyelash
6.11 Mar 08, 2018: Ocular Therapeutix Reports Fourth Quarter and Year End 2017 Financial Results and Business Update
6.12 Mar 01, 2018: New data on the CyPass Micro-Stent find fewer disease progression events, reduced dependence on traditional medications in glaucoma patients undergoing cataract surgery
6.13 Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results
6.14 Feb 28, 2018: Raysearch Laboratories: First clinic now live with RayCare
6.15 Feb 28, 2018: STAAR Surgical Reports Fourth Quarter and Full Year 2017 Results
6.16 Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results
6.17 Feb 27, 2018: International Study Shows Long-Term Titrated IOP Control with 1, 2 or 3 Glaukos iStent Trabecular Micro-Bypass Stents in Open-Angle Glaucoma Patients
6.18 Feb 27, 2018: Ellex Medical Lasers: Release of Financial Results for Half-Year ended 31 December 2017
6.19 Feb 08, 2018: Glaukos iStent Trabecular Micro-Bypass Stent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma, According to New Study
6.20 Feb 05, 2018: CyPass Ushers in Exciting New Era of Glaucoma Treatment
6.21 Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer
6.22 Feb 05, 2018: Ellex: Trading Update for Half-Year Ended 31 December 2017
6.23 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.24 Jan 26, 2018: OPKO Health Announces Resignation Of Gregory Henderson As President Of BioReference Laboratories
6.25 Jan 08, 2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference
6.26 Jan 04, 2018: Sight Sciences Expands Surgical Portfolio with FDA Clearance of the OMNI Surgical System
6.27 Jan 03, 2018: Glaukos Submits IDE Application to FDA to Study iStent infinite Trabecular Micro-Bypass System
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 9: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Intraocular Pressure Monitoring System - Product Status
Table 11: Intraocular Pressure Monitoring System - Product Description
Table 12: Camras Vision Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Camras Shunt - Product Status
Table 14: Camras Shunt - Product Description
Table 15: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Glaucoma Device - Product Status
Table 17: Glaucoma Device - Product Description
Table 18: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Therapeutic Ultrasound Device - Glaucoma - Product Status
Table 20: Therapeutic Ultrasound Device - Glaucoma - Product Description
Table 21: Eye Sonix - Ongoing Clinical Trials Overview
Table 22: Therapeutic Ultrasound Device - Glaucoma - A Single-Center, Randomized, Double-Masked, 8-week Pilot Study Evaluating the Safety and Efficacy of the TUG Compared to Sham in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension
Table 23: Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Titan Shunt - Product Status
Table 25: Titan Shunt - Product Description
Table 26: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Microsystem Implant - Product Status
Table 28: Microsystem Implant - Product Description
Table 29: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 30: GTS400 - Product Status
Table 31: GTS400 - Product Description
Table 32: iStent Infinite - Product Status
Table 33: iStent Infinite - Product Description
Table 34: iStent inject Trabecular Micro-Bypass Stent - Product Status
Table 35: iStent inject Trabecular Micro-Bypass Stent - Product Description
Table 36: iStent SA - Product Status
Table 37: iStent SA - Product Description
Table 38: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status
Table 39: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description
Table 40: Glaukos Corp - Ongoing Clinical Trials Overview
Table 41: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B
Table 42: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
Table 43: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent
Table 44: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With One Suprachoroidal Stent
Table 45: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin
Table 46: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery
Table 47: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
Table 48: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent
Table 49: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of the Second Generation iStent Inject in Open-angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications
Table 50: iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized Evaluation of Subjects with Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naive to Medical and Surgical Therapy, Treated with Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%
Table 51: iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery
Table 52: iStent inject Trabecular Micro-Bypass Stent - A Randomized Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery with Insertion of iStent Inject
Table 53: iStent SA - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B
Table 54: iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject)
Table 55: iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin
Table 56: iStent SA - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject
Table 57: iStent SA - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients with Glaucoma or Ocular Hypertension: An Observational Study
Table 58: iStent SA - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
Table 59: iStent SA - US Investigational Device Exemption (IDE) Pivotal Study of iStent SA Standalone Micro-Invasive Glaucoma Surgery
Table 60: iStent Infinite - A Prospective, Multi-center, Single-arm Clinical Study to Evaluate the Safety and Efficacy of iStent Infinite in Refractory Glaucoma Patients
Table 61: iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 62: MINIject - Product Status
Table 63: MINIject - Product Description
Table 64: STARflo MINI - Product Status
Table 65: STARflo MINI - Product Description
Table 66: STARflo Plus Glaucoma Implant - Product Status
Table 67: STARflo Plus Glaucoma Implant - Product Description
Table 68: iSTAR Medical SA - Ongoing Clinical Trials Overview
Table 69: MINIject - A Prospective, Open, Multicenter Clinical Trial with One Cohort Analyzing the Efficacy and Safety of MINIject in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Table 70: MINIject - A Prospective, Open, Multicentre Clinical Trial Analyzing the Effectiveness and Safety of MINIject 636 in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Table 71: Ivantis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Hydrus Microstent - Product Status
Table 73: Hydrus Microstent - Product Description
Table 74: Ivantis Inc - Ongoing Clinical Trials Overview
Table 75: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Table 76: Hydrus Microstent - Evaluation of Safety and Efficacy of the Hydrus Microstent in Treatment of Patients with Advanced Glaucoma
Table 77: Hydrus Microstent - MIGS Versus SLT in Glaucoma Patients: Prospective Study
Table 78: Hydrus Microstent - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients with Glaucoma or Ocular Hypertension: An Observational Study
Table 79: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial
Table 80: iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 81: IVMED-70 - Product Status
Table 82: IVMED-70 - Product Description
Table 83: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Partially Degradable Glaucoma Stent - Product Status
Table 85: Partially Degradable Glaucoma Stent - Product Description
Table 86: Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 87: MACC-Based Device - Glaucoma Filtering - Product Status
Table 88: MACC-Based Device - Glaucoma Filtering - Product Description
Table 89: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Pressure Relief Valve Shunt - Product Status
Table 91: Pressure Relief Valve Shunt - Product Description
Table 92: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 93: CellPlant - Product Status
Table 94: CellPlant - Product Description
Table 95: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Glaucoma Drainage Device - Product Status
Table 97: Glaucoma Drainage Device - Product Description
Table 98: Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Drainage Viscoelastic Injectable Implant - Product Status
Table 100: Drainage Viscoelastic Injectable Implant - Product Description
Table 101: MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Brown Glaucoma Implant (BGI) - Product Status
Table 103: Brown Glaucoma Implant (BGI) - Product Description
Table 104: MicroOptx, Inc. - Ongoing Clinical Trials Overview
Table 105: Brown Glaucoma Implant (BGI) - Early Feasibility Study of the Brown Glaucoma Implant in Patients with No Light Perceived
Table 106: Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
Table 107: CaPRI Device - Product Status
Table 108: CaPRI Device - Product Description
Table 109: OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Deep Wave Trabeculoplasty Device - Product Status
Table 111: Deep Wave Trabeculoplasty Device - Product Description
Table 112: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Aquashunt - Product Status
Table 114: Aquashunt - Product Description
Table 115: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Lipshitz Macular Implant - Advanced Glaucoma - Product Status
Table 117: Lipshitz Macular Implant - Advanced Glaucoma - Product Description
Table 118: Queen's University Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Laser Adjustable Suture - Product Status
Table 120: Laser Adjustable Suture - Product Description
Table 121: Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 122: InnFocus Microshunt - Product Status
Table 123: InnFocus Microshunt - Product Description
Table 124: Santen Pharmaceutical Co Ltd - Ongoing Clinical Trials Overview
Table 125: InnFocus Microshunt - A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShunt Glaucoma Drainage System to Standard Trabeculectomy In Subjects with Primary Open Angle Glaucoma
Table 126: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Toroidal Glaucoma Drainage Device - Product Status
Table 128: Toroidal Glaucoma Drainage Device - Product Description
Table 129: Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 130: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Status
Table 131: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Description
Table 132: Sight Sciences Inc - Ongoing Clinical Trials Overview
Table 133: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Multi-center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma
Table 134: SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 135: SOLX Gold Shunt - Product Status
Table 136: SOLX Gold Shunt - Product Description
Table 137: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Direct Laser Trabeculoplasty System - Product Status
Table 139: Direct Laser Trabeculoplasty System - Product Description
Table 140: Glaucoma Implant - Product Status
Table 141: Glaucoma Implant - Product Description
Table 142: TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: EasyIOP - Product Status
Table 144: EasyIOP - Product Description
Table 145: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Aqueous Humor Micro-Bypass Shunt - Product Status
Table 147: Aqueous Humor Micro-Bypass Shunt - Product Description
Table 148: Glaucoma Device - Product Status
Table 149: Glaucoma Device - Product Description
Table 150: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Integrated Magnetoelastic Actuator - Product Status
Table 152: Integrated Magnetoelastic Actuator - Product Description
Table 153: University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Nanoscale Plates - Product Status
Table 155: Nanoscale Plates - Product Description
Table 156: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview
Table 157: PTX-Eluting Microstent - Product Status
Table 158: PTX-Eluting Microstent - Product Description
Table 159: Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 160: Pneumatic Trabeculoplasty System - Product Status
Table 161: Pneumatic Trabeculoplasty System - Product Description
Table 162: Glossary
1.2 List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report